Myriad Genetics
MYGN
#7315
Rank
S$0.72 B
Marketcap
S$7.57
Share price
-5.88%
Change (1 day)
-10.17%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2023 (TTM): S-$4.13

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is S-$1.52. In 2022 the company made an earnings per share (EPS) of S-$1.78 a decrease over its 2021 EPS that were of S-$0.47.

EPS history for Myriad Genetics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$4.13131.95%
2022S-$1.78275.68%
2021S-$0.47-87.99%
2020S-$3.94755.56%
2019S-$0.46-194.74%
2018S$0.49-79.89%
2017S$2.42112.36%
2016S$1.14-35.97%
2015S$1.78-7.33%
2014S$1.92-37.24%
2013S$3.0659.33%
2012S$1.9220.97%
2011S$1.59-10.79%
2010S$1.7814.88%
2009S$1.5512.04%
2008S$1.38-454.1%
2007S-$0.39-42.45%
2006S-$0.68-8.62%
2005S-$0.74-18.88%
2004S-$0.9122.22%
2003S-$0.7525.81%
2002S-$0.59200%
2001S-$0.20-13.89%
2000S-$0.23-20.88%
1999S-$0.29-24.79%
1998S-$0.3961.33%
1997S-$0.24-34.21%
1996S-$0.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
S$3.46-327.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S-$6.81 347.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S-$65.13 4,177.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$10.66-800.00%๐Ÿ‡บ๐Ÿ‡ธ USA